504 related articles for article (PubMed ID: 21747278)
1. Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy.
Mitra S; Deshmukh A; Sachdeva R; Lu J; Mehta JL
Am J Med Sci; 2011 Aug; 342(2):135-42. PubMed ID: 21747278
[TBL] [Abstract][Full Text] [Related]
2. Oxidized LDL, LOX-1 and atherosclerosis.
Mitra S; Goyal T; Mehta JL
Cardiovasc Drugs Ther; 2011 Oct; 25(5):419-29. PubMed ID: 21947818
[TBL] [Abstract][Full Text] [Related]
3. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.
Mehta JL
Can J Cardiol; 2004 Aug; 20 Suppl B():32B-36B. PubMed ID: 15309203
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in atherogenesis and tumorigenesis.
Lu J; Mitra S; Wang X; Khaidakov M; Mehta JL
Antioxid Redox Signal; 2011 Oct; 15(8):2301-33. PubMed ID: 21338316
[TBL] [Abstract][Full Text] [Related]
5. Ethanol extract of propolis protects endothelial cells from oxidized low density lipoprotein-induced injury by inhibiting lectin-like oxidized low density lipoprotein receptor-1-mediated oxidative stress.
Fang Y; Li J; Ding M; Xu X; Zhang J; Jiao P; Han P; Wang J; Yao S
Exp Biol Med (Maywood); 2014 Dec; 239(12):1678-87. PubMed ID: 24962173
[TBL] [Abstract][Full Text] [Related]
6. Klotho ameliorates oxidized low density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways.
Yao Y; Wang Y; Zhang Y; Liu C
Lipids Health Dis; 2017 Apr; 16(1):77. PubMed ID: 28407763
[TBL] [Abstract][Full Text] [Related]
7. Role of Ox-LDL and LOX-1 in Atherogenesis.
Kattoor AJ; Kanuri SH; Mehta JL
Curr Med Chem; 2019; 26(9):1693-1700. PubMed ID: 29737246
[TBL] [Abstract][Full Text] [Related]
8. Novel concepts in the genesis of hypertension: role of LOX-1.
Luo P; Yan M; Frohlich ED; Mehta JL; Hu C
Cardiovasc Drugs Ther; 2011 Oct; 25(5):441-9. PubMed ID: 21912849
[TBL] [Abstract][Full Text] [Related]
9. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis.
Chen J; Liu Y; Liu H; Hermonat PL; Mehta JL
Biochem J; 2006 Jan; 393(Pt 1):255-65. PubMed ID: 16173915
[TBL] [Abstract][Full Text] [Related]
10. Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells: role of reactive oxygen species.
Sun Y; Chen X
Fundam Clin Pharmacol; 2011 Oct; 25(5):572-9. PubMed ID: 21077940
[TBL] [Abstract][Full Text] [Related]
11. Effects of flow on LOX-1 and oxidized low-density lipoprotein interactions in brain endothelial cell cultures.
Mao X; Xie L; Greenberg DA
Free Radic Biol Med; 2015 Dec; 89():638-41. PubMed ID: 26462413
[TBL] [Abstract][Full Text] [Related]
12. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders.
Mehta JL; Chen J; Hermonat PL; Romeo F; Novelli G
Cardiovasc Res; 2006 Jan; 69(1):36-45. PubMed ID: 16324688
[TBL] [Abstract][Full Text] [Related]
13. Protamine may have anti-atherogenic potential by inhibiting the binding of oxidized-low density lipoprotein to LOX-1.
Takemura Y; Okamoto M; Hasegawa M; Hatanaka K; Kubota S
Biosci Biotechnol Biochem; 2019 Jun; 83(6):1094-1101. PubMed ID: 30871430
[TBL] [Abstract][Full Text] [Related]
14. LOX-1 and ROS, inseparable factors in the process of endothelial damage.
Lubrano V; Balzan S
Free Radic Res; 2014 Aug; 48(8):841-8. PubMed ID: 24886290
[TBL] [Abstract][Full Text] [Related]
15. Modulation of oxidized-LDL receptor-1 (LOX1) contributes to the antiatherosclerosis effect of oleanolic acid.
Jiang Q; Wang D; Han Y; Han Z; Zhong W; Wang C
Int J Biochem Cell Biol; 2015 Dec; 69():142-52. PubMed ID: 26510581
[TBL] [Abstract][Full Text] [Related]
16. Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?
Chen XP; Zhang TT; Du GH
Cardiovasc Drug Rev; 2007; 25(2):146-61. PubMed ID: 17614937
[TBL] [Abstract][Full Text] [Related]
17. LOX-1 receptor: A potential link in atherosclerosis and cancer.
Balzan S; Lubrano V
Life Sci; 2018 Apr; 198():79-86. PubMed ID: 29462603
[TBL] [Abstract][Full Text] [Related]
18. Degradation of heparan sulfate proteoglycans enhances oxidized-LDL-mediated autophagy and apoptosis in human endothelial cells.
Ding Z; Wang X; Khaidakov M; Liu S; Dai Y; Mehta JL
Biochem Biophys Res Commun; 2012 Sep; 426(1):106-11. PubMed ID: 22910414
[TBL] [Abstract][Full Text] [Related]
19. Lectin-like oxidized LDL receptor-1 expresses in mouse bone marrow-derived mesenchymal stem cells and stimulates their proliferation.
Zhang F; Wang C; Jing S; Ren T; Li Y; Cao Y; Lin J
Exp Cell Res; 2013 Apr; 319(7):1054-9. PubMed ID: 23399833
[TBL] [Abstract][Full Text] [Related]
20. [Autophagy of human vascular endothelial cells by oxidized low-density lipoprotein: involvement of oxidative stress but no oxidized low density lipoprotein-1].
Han Q; Zhang YL; You SJ; Liu HH; Cao YJ; Chen R; Liu CF
Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(31):2216-20. PubMed ID: 22094043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
